Original ArticleStability-indicating assay method for determination of Actarit (cas 18699-02-0), its process related impurities and degradation products: Insight into stability profile and degradation pathways☆☆

Add time:09/24/2019    Source:sciencedirect.com

The stability of the drug actarit was studied under different stress conditions like hydrolysis (acid, alkaline and neutral), oxidation, photolysis and thermal degradation as recommended by International Conference on Harmonization (ICH) guidelines. Drug was found to be unstable in acidic, basic and photolytic conditions and produced a common degradation product while oxidative stress condition produced three additional degradation products. Drug was impassive to neutral hydrolysis, dry thermal and accelerated stability conditions. Degradation products were identified, isolated and characterized by different spectroscopic analyses. Drug and the degradation products were synthesized by a new route using green chemistry. The chromatographic separation of the drug and its impurities was achieved in a phenomenex luna C18 column employing a step gradient elution by high performance liquid chromatography coupled to photodiode array and mass spectrometry detectors (HPLC–PDA–MS). A specific and sensitive stability-indicating assay method for the simultaneous determination of the drug actarit, its process related impurities and degradation products was developed and validated.

We also recommend Trading Suppliers and Manufacturers of Actarit (cas 18699-02-0). Pls Click Website Link as below: cas 18699-02-0 suppliers

Prev:Original Research PaperDouble-layered osmotic pump controlled release tablets of Actarit (cas 18699-02-0): In vitro and in vivo evaluation
Next:Pharmaceutical NanotechnologyInjectable Actarit (cas 18699-02-0)-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis)